The R&D pipeline reflects our long-term commitment to driving change to defeat obesity, haemophilia, growth disorders and other serious chronic diseases
Facts and figures specific to our Research & Development organisation
We have teamed up with the International Red Cross and Red Crescent Movement to solve the challenge of delivering care to vulnerable populations displaced by conflict.
Click through to find the answers to some of our more frequently asked questions on sustainability and responsible business practices.
We are driven by science, innovation and research and strive to share our knowledge with the global community.
FlexPen® is available prefilled with Novo Nordisk
Read more about our insulin
Like this? You may also be interested in:
Develop a routine for successful
Living with your pen
Glucose & insulin: keeping track
Look at the full range of Novo Nordisk
HQMMA/DV/0117/0005. February 2017.